- Scientists are reporting success treating advanced lung cancer with drugs such as nivolumab
- The drug helped a quarter of 129 US patients with advanced lung cancer survive two years
- Nivolumab is one of a new class of drug, called anti-PD1s and anti-PDL1s
Extraordinary new drugs have cleared tumours that have spread throughout lung cancer patients’ whole bodies, scientists say.
Some are even talking of the new immunotherapy drugs effectively curing patients of the disease, which has a grim survival record.
After lung cancer has spread to other organs – and by the time it’s spotted, it usually has – most patients die within months.